Pharmaceutical Lifecycle ManagementCutting Edge InformationSeptember 1, 2010 152 Pages - SKU: CIGQ2879678 |
| As short-term concerns naturally dominate commercial activity, lifecycle management (LCM) is a keystone to strategic, long-term brand planning. Faced with shrinking market exclusivity, evolving branded competitors, aggressive generics — and, overall, less time to recoup investments — drug companies devise robust strategies to prolong brand life and value. Successful teams plan carefully — and give themselves plenty of time to execute their strategies, which may take years to bear fruit. In best-case scenarios, centralized LCM groups collaborate across functions to knock down silos and focus all stakeholders on long-term brand success. Empower your lifecycle management team and track the effectiveness of different LCM strategies:
|
Related Markets
- Pharmaceuticals
- Pharmaceuticals Company Reports
- Generics Drugs
- Manufacturing, Packaging & Detailing
- Prescription Drugs
Prescription Drugs Reports
- Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program
- Chinese Markets for Hepatitis Drugs
- Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion
